It is time to rethink H. pylori therapy.
作者信息
Dang Bich N, Graham David Y
机构信息
Michael E. DeBakey VA Medical Center, Houston, Texas, U.S.A.
出版信息
J Gastrointestin Liver Dis. 2017 Jun;26(2):115-117. doi: 10.15403/jgld.2014.1121.262.hpy.
Abstract
摘要
相似文献
1
It is time to rethink H. pylori therapy.是时候重新思考幽门螺杆菌的治疗方法了。
J Gastrointestin Liver Dis. 2017 Jun;26(2):115-117. doi: 10.15403/jgld.2014.1121.262.hpy.
2
[Update H. pylori therapy].[更新幽门螺杆菌治疗方案]
MMW Fortschr Med. 2018 Nov;160(19):61-64. doi: 10.1007/s15006-018-1090-z.
3
Outcomes of furazolidone- and amoxicillin-based quadruple therapy for infection and predictors of failed eradication.呋喃唑酮和阿莫西林四联疗法治疗感染的结果及根除失败的预测因素。
World J Gastroenterol. 2018 Oct 28;24(40):4596-4605. doi: 10.3748/wjg.v24.i40.4596.
4
Helicobacter pylori Eradication?根除幽门螺杆菌？
Gastroenterology. 2016 Oct;151(4):773-4. doi: 10.1053/j.gastro.2016.05.059. Epub 2016 Aug 30.
5
Second-line rescue treatment of infection: Where are we now?二线解救治疗 感染：我们现在在哪里？
World J Gastroenterol. 2018 Oct 28;24(40):4548-4553. doi: 10.3748/wjg.v24.i40.4548.
6
Response to: Reply on "Renewed Helicobacter pylori management and therapy in 2015".对《2015年幽门螺杆菌管理与治疗的更新》的回复：答复
Saudi J Gastroenterol. 2016 Jan-Feb;22(1):81. doi: 10.4103/1319-3767.173766.
7
8
Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.左氧氟沙星、阿莫西林和埃索美拉唑对幽门螺杆菌感染初始治疗及治疗失败后初步药敏试验的作用
Helicobacter. 2006 Aug;11(4):237-42. doi: 10.1111/j.1523-5378.2006.00407.x.
9
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.三联疗法与双重疗法根除幽门螺杆菌及预防溃疡复发的比较：一项关于兰索拉唑、克拉霉素和/或阿莫西林不同给药方案的随机、双盲、多中心研究。
Am J Gastroenterol. 1998 Apr;93(4):584-90. doi: 10.1111/j.1572-0241.1998.169_b.x.
10
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.在各种治疗策略中，联合治疗对幽门螺杆菌的根除率最高。
World J Gastroenterol. 2015 Jan 7;21(1):351-9. doi: 10.3748/wjg.v21.i1.351.
引用本文的文献
1
Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Therapy.抗菌药物管理危机：克拉霉素治疗的不当使用
Pharmacoepidemiology. 2024 Mar;3(1):82-93. doi: 10.3390/pharma3010006. Epub 2024 Feb 20.
2
Best Practices for Management.管理的最佳实践
Gastroenterol Hepatol (N Y). 2024 Mar;20(3):159-168.
3
Controversies regarding management of Helicobacter pylori infections.关于幽门螺杆菌感染处理的争议。
Curr Opin Gastroenterol. 2023 Nov 1;39(6):482-489. doi: 10.1097/MOG.0000000000000981. Epub 2023 Sep 5.
4
Implications of the paradigm shift in management of infections.感染管理模式转变的影响
Therap Adv Gastroenterol. 2023 Mar 18;16:17562848231160858. doi: 10.1177/17562848231160858. eCollection 2023.
5
Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.质子泵抑制剂的相对效力、幽门螺杆菌治疗的治愈率以及双倍剂量 PPI 的意义。
Helicobacter. 2019 Feb;24(1):e12554. doi: 10.1111/hel.12554. Epub 2018 Nov 15.
6
Illusions regarding clinical trials and treatment guidelines.关于临床试验和治疗指南的错觉。
Gut. 2017 Dec;66(12):2043-2046. doi: 10.1136/gutjnl-2017-314744. Epub 2017 Sep 21.
本文引用的文献
1
Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe.意大利幽门螺杆菌感染异质性管理患者的根除率。是时候摒弃南欧的经验性治疗了。
J Gastrointestin Liver Dis. 2017 Jun;26(2):129-137. doi: 10.15403/jgld.2014.1121.262.itl.
2
Helicobacter pylori infection and antibiotic resistance: a WHO high priority?幽门螺杆菌感染和抗生素耐药性：世卫组织的高度优先事项？
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):383-384. doi: 10.1038/nrgastro.2017.57. Epub 2017 May 3.
3
Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.有效治疗幽门螺杆菌，同时最大限度减少抗生素滥用。
Cleve Clin J Med. 2017 Apr;84(4):310-318. doi: 10.3949/ccjm.84a.14110.
4
Helicobacter pylori therapy: a paradigm shift.幽门螺杆菌治疗：范式转变。
Expert Rev Anti Infect Ther. 2016 Jun;14(6):577-85. doi: 10.1080/14787210.2016.1178065. Epub 2016 May 3.
5
Role of bismuth in improving Helicobacter pylori eradication with triple therapy.铋在三联疗法提高幽门螺杆菌根除率中的作用。
Gut. 2016 May;65(5):870-8. doi: 10.1136/gutjnl-2015-311019. Epub 2016 Feb 4.
6
Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection.阿奇霉素与多西环素治疗泌尿生殖系统沙眼衣原体感染的比较
N Engl J Med. 2015 Dec 24;373(26):2512-21. doi: 10.1056/NEJMoa1502599.
7
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.如何有效使用铋剂四联疗法：优点、缺点与问题
Gastroenterol Clin North Am. 2015 Sep;44(3):537-63. doi: 10.1016/j.gtc.2015.05.003. Epub 2015 Jun 19.
8
Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.质子泵抑制剂的相对效价——对胃内pH值影响的比较
Eur J Clin Pharmacol. 2009 Jan;65(1):19-31. doi: 10.1007/s00228-008-0576-5. Epub 2008 Oct 17.
9
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.老年消化性溃疡患者序贯疗法根除幽门螺杆菌的高根除率：一项前瞻性对照研究。
Aliment Pharmacol Ther. 2005 Jun 15;21(12):1419-24. doi: 10.1111/j.1365-2036.2005.02519.x.
10
Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy.幽门螺杆菌根除治疗在意大利基层医疗环境中的有效性。
Aliment Pharmacol Ther. 2002 Jul;16(7):1269-75. doi: 10.1046/j.1365-2036.2002.01244.x.
Zotero 插件